Skip to content

Clinical trials

Phase 4 Acquired Immunodeficiency Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 4 Clear all

211 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20026
20035
20049
20059
20069
200710
200815
200912
20109
201112
20123
20136
20144
20159
20169
201711
20188
20198
202010
202114
20225
20238
20242
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed138
Terminated23
Unknown status21
Recruiting11
Withdrawn9
Not yet recruiting3
Enrolling by invitation3
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare9
Community Research Initiative of New England6
University of California, San Francisco6
Emory University4
University of Maryland, Baltimore4
University of Washington4
Yale University4
Bristol-Myers Squibb3
Catholic University of the Sacred Heart3
Centers for Disease Control and Prevention3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome211
HIV Infections72
Hepatitis C13
Tuberculosis12
Infections7
Opioid-Related Disorders6
Substance-Related Disorders5
Cardiovascular Diseases4
Dyslipidemias4
Anemia3

Trials

Showing 76 to 100 of 211. Each trial links to its page on Pharma Observatory.

111 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.